Eleonora Sosa Cuevas

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Prognostic Factors

Ejection Fraction

Immune Response

Top Venues

Clinical & translational immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Camille Niveau, Eleonora Sosa Cuevas, Philippe Saas, Caroline Aspord
Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy. Immunology 173 (1) (2024)
Camille Niveau, Eleonora Sosa Cuevas, Philippe Saas, Caroline Aspord
Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy. Immunology (2024)
Eleonora Sosa Cuevas, Philippe Saas, Caroline Aspord
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation. Cancers 15 (8) (2023)
Eleonora Sosa Cuevas, Philippe Saas, Caroline Aspord
Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation. Cancers 15 (8) (2023)
Eleonora Sosa Cuevas, Nathalie Bendriss-Vermare, Stephane Mouret, Florence De Fraipont, Julie Charles, Jenny Valladeau-Guilemond, Laurence Chaperot, Caroline Aspord
Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80 + PDL1 - )-pDC subset negatively correlated with clinical outcomes in melanoma patients. Clinical & translational immunology 11 (5) (2022)
Pauline Girard, Eleonora Sosa Cuevas, Benedicte Ponsard, Stephane Mouret, Hugo Gil, Edwige Col, Florence De Fraipont, Nathalie Sturm, Julie Charles, Olivier Manches, Laurence Chaperot, Caroline Aspord
Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. Clinical & translational immunology 10 (11) (2021)
Laurissa Ouaguia, Tania Dufeu-Duchesne, Vincent Leroy, Thomas Decaens, Jean-Baptiste Reiser, Eleonora Sosa Cuevas, David Durantel, Jenny Valladeau-Guilemond, Nathalie Bendriss-Vermare, Laurence Chaperot, Caroline Aspord
Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs. Clinical & translational immunology 9 (12) (2020)
Eleonora Sosa Cuevas, Laurissa Ouaguia, Stephane Mouret, Julie Charles, Florence De Fraipont, Olivier Manches, Jenny Valladeau-Guilemond, Nathalie Bendriss-Vermare, Laurence Chaperot, Caroline Aspord
BDCA1+ cDC2s, BDCA2+ pDCs and BDCA3+ cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients. Clinical & translational immunology 9 (11) (2020)